Expertise in
4
conditions

Pierre Frange

Paris, FR 
Expertise in
4
conditions
Paris, FR 

Overview

Pierre Frange practices practicing medicine in Paris, France.

Mr. Frange is highly rated in 4 conditions, according to our data. His clinical expertise encompasses HIV/AIDS, Fifth Disease, Primary Immunodeficiency (PID), Bone Marrow Transplant, and Lung Transplant.

He is actively involved in clinical research, co-authoring 127 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Paris, France

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
A Phase 3, Multicenter, Randomized, Open-label, Active-controlled Study to Assess the Efficacy and Safety of Maribavir Treatment Compared to Investigator-assigned Treatment in Transplant Recipients With Cytomegalovirus (CMV) Infections That Are Refractory or Resistant to Treatment With Ganciclovir, Valganciclovir, Foscarnet, or Cidofovir
Enrollment Status: Completed
Publish Date: November 03, 2021
Intervention Type: Drug
Study Phase: Phase 3
ANRS EP59 CLEAC : Physiopathological Study of Immunovirological Evolution of Perinatally HIV-1 Infected Children Depending on Early (Before 6 Months) or Late (After 2 Years) Antiretroviral Therapy Introduction.
ANRS EP59 CLEAC : Physiopathological Study of Immunovirological Evolution of Perinatally HIV-1 Infected Children Depending on Early (Before 6 Months) or Late (After 2 Years) Antiretroviral Therapy Introduction.
Enrollment Status: Unknown
Publish Date: January 18, 2019
Intervention Type: Other
Study Phase: Not Applicable
View 1 Less Clinical Trial

127 Total Publications

Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial.
Better 10-Year Cerebrovascular Outcome After Transplant Than on Standard-Care in Sickle Cell Anemia: DREPAGREFFE Trial.
Journal: American journal of hematology
Published: January 13, 2026

Frequently Asked Questions about Pierre Frange

Is Pierre Frange a top-rated expert for HIV/AIDS?

MediFind is an objective health platform that identifies experts based on real-world data. Pierre Frange is classified as an Advanced expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Pierre Frange participate in research or clinical trials?

Yes. Pierre Frange has published 127 articles and abstracts on conditions like HIV/AIDS. You can view a list of Pierre Frange's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Frange's expertise for a condition
ConditionClose
      View All 38 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile